10X Genomics Inc Class A (TXG)
10X Genomics stock today
10X Genomics closed at $70.11 on October 30, 2026, down 14.03% on the day. Over the past year it returned +463.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $8.90 billion.
| Period | TXG | S&P 500 (SPY) |
|---|---|---|
| 1 month | -22.4% | -0.9% |
| 3 months | +41.8% | +2.1% |
| Year to date | +329.9% | +11.7% |
| 1 year | +463.6% | +12.4% |
| 3 years | +96.1% | +88.5% |
| 5 years | -56.5% | +76.0% |
Key statistics
- Market value
- $8.90B
- Price / sales
- 14.4
- 52-week range
- $12.44 to $97.74
- Next report
- Nov 5, 2026
About 10X Genomics
10X Genomics manufactures and sells instruments and consumables for single-cell and spatial genomics analysis.
Sector: Health Care
More on 10X Genomics
- Financials: revenue, earnings and segmentsRevenue +5% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $434.74 today
No forecast, no recommendation. This page describes 10X Genomics Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.